Hologic, Inc. (HOLX) Rating Lowered to Hold at Evercore ISI
A number of other research firms have also commented on HOLX. Zacks Investment Research lowered Hologic from a "buy" rating to a "hold" rating in a research note on Monday, November 7th.
from Biotech News
0 Comments